Neuroscientific Biopharmaceuticals Ltd
Biopharmaceutical innovation and world class R&D
NSB (ASX:NSB) is a drug development company focused on developing peptide-based pharmaceutical drugs for the treatment of neurodegenerative conditions with high unmet medical need.
The NSB product portfolio includes several therapeutic peptides that are modeled on the domains of a naturally occurring protein called Metallothionein-II (MT-II).
EmtinB is the lead candidate that has shown to closely mimic the neuroprotective and neuroregenerative ability of MT-II.
Spotlight Videos
NeuroScientific Biopharmaceuticals (ASX: NSB) – Webinar Presentation
All Neuroscientific Biopharmaceuticals Ltd Content